|
Yale Cancer Center NCTN
|
3U10CA180826-03S1
|
$49,901
|
$2,495
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
Yale Cancer Center NCTN
|
5U10CA180826-04
|
$951,500
|
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
Yale Cancer Center NCTN
|
5U10CA180826-04
|
$951,500
|
$47,575
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
XLF in double-strand break repair and chemo/radiosensitization
|
5R01CA166264-05
|
$307,700
|
|
POVIRK, LAWRENCE
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Particip
|
5U10CA180864-04
|
$542,798
|
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Particip
|
5U10CA180864-04
|
$542,798
|
$10,856
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
VPAC1 Recpetor-Targeted PET Imaging of Prostate Cancer
|
5R01CA157372-06
|
$380,300
|
|
THAKUR, MATHEW
|
THOMAS JEFFERSON UNIVERSITY
|
|
Visualization and Epigenomic Characterization of Early Intestinal Tumorigenesis in Mice
|
1R01CA212374-01
|
$434,625
|
|
LAIRD, PETER
|
VAN ANDEL RESEARCH INSTITUTE
|
|
Vascular communication in metastatic brain colonization
|
5R01CA184594-04
|
$321,625
|
|
KLEMKE, RICHARD
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Varicella virus antigens in glioma etiology and survival
|
5U01CA182371-04
|
$552,893
|
|
WIEMELS, JOSEPH
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
5U10CA180847-05
|
$592,247
|
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Validation of the Pre-BCR Signaling Complex in pre-B ALL Cell Model by Two-Color Single Particle Tracking and Peptidomimetic Inhibition
|
5F31CA192848-03
|
$8,966
|
|
ERASMUS, MICHAEL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
Validation of Methylated Vimentin as a Diagnostic Test for Barrett's Esophagus
|
5UH2CA205105-02
|
$317,889
|
$317,889
|
WILLIS, JOSEPH
|
CASE WESTERN RESERVE UNIVERSITY
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
3U10CA180870-03S1
|
$50,000
|
$625
|
GERBER, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
5U10CA180870-04
|
$700,000
|
|
GERBER, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
5U10CA180870-04
|
$700,000
|
$8,750
|
GERBER, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
5U10CA180858-04
|
$688,299
|
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
5U10CA180858-04
|
$688,299
|
$8,604
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Unraveling the molecular control of a pro-metastatic regulatory network in melanoma
|
5R01CA184804-02
|
$387,731
|
|
TAVAZOIE, SOHAIL
|
ROCKEFELLER UNIVERSITY
|
|
Unraveling the Function of RNA-Binding proteins in B-lympoblastic Leukemia
|
5R21CA197441-02
|
$200,970
|
|
RAO, DINESH
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S3
|
$6,166,044
|
$123,321
|
FEARON, ERIC
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S4
|
$50,000
|
$1,000
|
FEARON, ERIC
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S5
|
$30,973
|
$619
|
FEARON, ERIC
|
UNIVERSITY OF MICHIGAN
|
|
University of Colorado NTCN Lead Academic Participating Site (LAPS)
|
5U10CA180834-04
|
$768,950
|
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER
|
|
Understanding the role of ?B-Ras proteins in tumorigenesis
|
5R01CA206556-02
|
$384,782
|
|
GHOSH, SANKAR
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Understanding the origin,initiation,and progression of high-grade serous ovarian cancer
|
5R00CA179137-04
|
$245,221
|
|
KIM, JAEYEON
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Understanding the AGL metastasis suppressor for therapeutic gain
|
5R01CA143971-07
|
$435,425
|
|
THEODORESCU, DAN
|
UNIVERSITY OF COLORADO DENVER
|
|
Understanding Spatially Regulated Tumor-Inhibitory Function of Profilin-1 and its Deregulation in Breast Cancer
|
1R01CA181671-01A1
|
$348,844
|
|
SHAO, JIEYA
|
WASHINGTON UNIVERSITY
|
|
Understanding How Ciliary Hedgehog Signaling Causes Medulloblastoma
|
1K08CA212279-01
|
$177,124
|
|
RALEIGH, DAVID
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Understanding Esophageal Adenocarcinoma Progression Using Inflammatory and Neoplastic Extracellular Matrix Hydrogels
|
5F31CA210694-02
|
$40,302
|
$40,302
|
SALDIN, LINDSEY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Understanding and Improving Platinum Anticancer Drugs
|
5R01CA034992-35
|
$674,719
|
|
LIPPARD, STEPHEN
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Uncovering the role of individual RNA helicases in cancer through specific chemical inhibition
|
5F30CA203522-02
|
$35,959
|
|
BARKOVICH, KRISTER
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
UGI cancer studies - other
|
ZIA CP000185-10319
|
$308,629
|
$308,629
|
Dawsey, Sandy
|
DCEG (NCI)
|
|
uCoil NMR platform for robust and high-throughput analysis of in vitro metabolic flux on living cells
|
1R21CA212958-01
|
$234,200
|
|
KESHARI, KAYVAN
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
UCDCCC NCTN U10 Program
|
5U10CA180846-04
|
$592,771
|
|
GANDARA, DAVID
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
TXNIP as a Key Regulator of Thyroid Cancer Metabolism and Aggressiveness
|
5R01CA175994-05
|
$322,663
|
|
HAUGEN, BRYAN
|
UNIVERSITY OF COLORADO DENVER
|
|
Tumor-stromal interactions as targets of tumor metastasis suppressors
|
5R01CA184494-03
|
$353,351
|
|
ROSNER, MARSHA
|
UNIVERSITY OF CHICAGO
|
|
Tumor Molecular Profiling and Response to Immunotherapy in Advanced Biliary Cancers
|
1R03CA212877-01
|
$79,250
|
|
KELLEY, ROBIN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$474,811
|
$23,741
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Tumor cytonemes, a new target for tumor suppression
|
5R21CA205580-02
|
$206,843
|
|
KORNBERG, THOMAS
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Transposon Insertion Polymorphisms in Predispositions to Hematopoietic Neoplasia
|
5R01CA163705-05
|
$336,150
|
|
BURNS, KATHLEEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Translational Research in Cancer
|
3P30CA056036-18S1
|
$58,442
|
$584
|
KNUDSEN, KAREN
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational Research in Cancer
|
3P30CA056036-18S2
|
$117,000
|
$1,170
|
KNUDSEN, KAREN
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational Research in Cancer
|
3P30CA056036-18S3
|
$175,000
|
$1,750
|
KNUDSEN, KAREN
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational Research in Cancer
|
5P30CA056036-18
|
$2,807,751
|
$28,078
|
KNUDSEN, KAREN
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translating Novel Antitumor Targets of Vitamin E into New Chemopreventive Agents
|
5R01CA172576-04
|
$319,550
|
|
CHEN, CHING-SHIH
|
OHIO STATE UNIVERSITY
|
|
Transcriptional Control of Leukemic Evolution in Primary Myelofibrosis
|
5R21CA195665-02
|
$174,000
|
|
NAORA, HONAMI
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Transcriptional CDKs as therapeutic targets in MYC-dependent cancers
|
5R01CA197336-02
|
$407,748
|
|
GEORGE, RANI
|
DANA-FARBER CANCER INST
|
|
Transcription repression in prostate cancer
|
5R01CA112226-08
|
$402,563
|
|
LOGAN, SUSAN
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Training Program in Basic Cancer Research
|
2T32CA009171-41
|
$591,366
|
|
MURPHY, MAUREEN
|
WISTAR INSTITUTE
|
Total relevant funding to Esophagus for this search: $35,234,155
|